5-HT2C receptor blockade reverses SSRI-associated basal ganglia dysfunction and potentiates therapeutic efficacy.
Demireva EY, Suri D, Morelli E, Mahadevia D, Chuhma N, Teixeira CM, Ziolkowski A, Hersh M, Fifer J, Bagchi S, Chemiakine A, Moore H, Gingrich JA, Balsam P, Rayport S, Ansorge MS.
Demireva EY, et al. Among authors: mahadevia d.
Mol Psychiatry. 2020 Dec;25(12):3304-3321. doi: 10.1038/s41380-018-0227-x. Epub 2018 Aug 17.
Mol Psychiatry. 2020.
PMID: 30120415
Free PMC article.